MarketCap
Facebook
X
TelegramGeschäftsbericht 2025
hinzugefügt 26.02.2026
GlycoMimetics Kurshistorie 2011-2026 | GLYC
Kurshistorie Jährlich GlycoMimetics
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | 0.28 | 3.18 | 1.38 | 1.44 | 3.76 | 5.29 | 9.47 | 16.8 | 6.1 | 5.72 | 7.2 | - | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 16.8 | 0.28 | 5.51 |
Kurshistorie anderer Aktien in der Pharmaeinzelhändler
| Name | Kurshistorie | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
 |
MorphoSys AG
MOR
|
18.2 | - | 2.43 % | $ 254 M |  Germany |
 |
Arbutus Biopharma Corporation
ABUS
|
4.42 | $ 4.5 | 0.45 % | $ 862 M |  Canada |
 |
ADC Therapeutics SA
ADCT
|
1.37 | $ 3.83 | 1.32 % | $ 105 M |  Schweiz |
 |
Agenus
AGEN
|
3.29 | $ 3.64 | 9.31 % | $ 108 M |  USA |
 |
Agios Pharmaceuticals
AGIO
|
28.1 | $ 35.08 | -0.36 % | $ 2.03 B | USA |
 |
Akebia Therapeutics
AKBA
|
1.3 | $ 1.39 | 0.36 % | $ 357 M | USA |
 |
Akari Therapeutics, Plc
AKTX
|
0.12 | $ 3.95 | -11.63 % | $ 266 B |  Britain |
 |
I-Mab
IMAB
|
0.68 | - | - | $ 866 M |  China |
 |
Genfit SA
GNFT
|
3.36 | - | 2.54 % | $ 160 B |  France |
 |
Aldeyra Therapeutics
ALDX
|
5.44 | $ 1.57 | -5.42 % | $ 94.3 M | USA |
 |
Aligos Therapeutics
ALGS
|
6.67 | $ 8.08 | 1.38 % | $ 79.9 M | USA |
 |
Biophytis SA
BPTS
|
0.33 | - | -13.47 % | $ 169 M | France |
 |
Alnylam Pharmaceuticals
ALNY
|
311 | $ 331.14 | 3.85 % | $ 43.4 B | USA |
 |
Altimmune
ALT
|
3.61 | $ 3.4 | 1.8 % | $ 300 M | USA |
 |
ALX Oncology Holdings
ALXO
|
2.13 | $ 1.99 | 0.81 % | $ 107 M | USA |
 |
Amgen
AMGN
|
369 | $ 344.03 | -1.12 % | $ 185 B | USA |
 |
Midatech Pharma plc
MTP
|
0.29 | - | -18.52 % | $ 27.3 M | Britain |
 |
Amneal Pharmaceuticals
AMRX
|
13.8 | $ 12.27 | -1.68 % | $ 3.85 B | USA |
 |
Anika Therapeutics
ANIK
|
25.4 | $ 14.99 | 1.28 % | $ 220 M | USA |
 |
Acorda Therapeutics
ACOR
|
13.5 | - | -24.86 % | $ 820 K | USA |
 |
ANI Pharmaceuticals
ANIP
|
61.9 | $ 73.8 | -0.55 % | $ 1.43 B | USA |
 |
Annexon
ANNX
|
4.96 | $ 5.56 | 1.0 % | $ 862 M | USA |
 |
Annovis Bio
ANVS
|
2.52 | $ 2.56 | 12.28 % | $ 52.6 M | USA |
 |
Adverum Biotechnologies
ADVM
|
3.86 | - | - | $ 86.2 M | USA |
 |
Advaxis
ADXS
|
0.31 | - | -9.65 % | $ 45.9 M | USA |
 |
Aptorum Group Limited
APM
|
0.75 | $ 0.88 | -5.16 % | $ 4.8 M | China |
 |
Applied Molecular Transport
AMTI
|
0.57 | - | - | $ 10.1 M | USA |
 |
Aprea Therapeutics
APRE
|
0.76 | $ 0.7 | -1.87 % | $ 4.58 M | USA |
 |
Aquestive Therapeutics
AQST
|
4.37 | $ 4.12 | -0.24 % | $ 441 M | USA |
 |
Aeterna Zentaris
AEZS
|
5.72 | - | 5.93 % | $ 314 M | Canada |
 |
AgeX Therapeutics
AGE
|
13 | - | -10.17 % | $ 12.2 K | USA |
 |
AIkido Pharma
AIKI
|
3.17 | - | 1.93 % | $ 17.4 M | USA |
 |
Arcturus Therapeutics Holdings
ARCT
|
7.93 | $ 8.14 | 1.31 % | $ 223 M |  Israel |
 |
Aeglea BioTherapeutics
AGLE
|
12 | - | - | $ 1.01 B | USA |
 |
Ardelyx
ARDX
|
6.73 | $ 5.99 | 0.84 % | $ 1.44 B | USA |
 |
Applied Genetic Technologies Corporation
AGTC
|
0.3 | - | - | $ 26.5 M | USA |
 |
Akero Therapeutics
AKRO
|
48.4 | - | - | $ 3.67 B | USA |
 |
Akouos
AKUS
|
5.34 | - | 0.23 % | $ 488 M | USA |
 |
argenx SE
ARGX
|
691 | $ 749.99 | 0.48 % | $ 25 B |  Niderland |
 |
Arcutis Biotherapeutics
ARQT
|
27.1 | $ 24.06 | 1.82 % | $ 3.06 B | USA |
 |
Arvinas
ARVN
|
12.2 | $ 10.87 | 0.14 % | $ 771 M | USA |
 |
Arrowhead Pharmaceuticals
ARWR
|
46.7 | $ 60.28 | -1.23 % | $ 8.06 B | USA |
 |
Allena Pharmaceuticals
ALNA
|
0.383 | - | 3.16 % | $ 1.9 M | USA |
 |
Assembly Biosciences
ASMB
|
27.5 | $ 29.51 | 1.72 % | $ 331 M | USA |
 |
Alpine Immune Sciences
ALPN
|
8.04 | - | - | $ 2.17 B | USA |
 |
Aileron Therapeutics
ALRN
|
2.13 | - | 10.36 % | $ 9.8 M | USA |
 |
Alterity Therapeutics Limited
ATHE
|
0.58 | $ 3.62 | 1.82 % | $ 8.71 B |  Australia |